Viral Antigens

Viral Antigens, Inc. is a biotechnology company specializing in the development and manufacture of high-quality viral reagents, antigens, and antibodies for the diagnostic and biopharmaceutical industries. Founded in 1982 and based in Memphis, Tennessee, the company provides a wide range of products for infectious diseases, including herpes simplex, cytomegalovirus, and hepatitis. In 2000, it was acquired by Meridian Bioscience, where it now operates as a core component of the Meridian Life Science division. The company offers both native and recombinant antigens, as well as contract manufacturing services for phase I/II clinical trials. Its Memphis facility is a cGMP-compliant site capable of large-scale production of critical assay reagents and biopharmaceutical products.